- $1.89bn
- $4.28bn
- $2.78bn
- 67
- 71
- 58
- 72
Annual income statement for Quidelortho, fiscal year end - December 29th, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2023 December 31st | 2023 January 1st | 2024 December 29th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,662 | 1,699 | 2,998 | 3,266 | 2,783 |
| Cost of Revenue | |||||
| Gross Profit | 1,349 | 1,271 | 1,494 | 1,936 | 1,287 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 612 | 792 | 2,859 | 2,446 | 4,744 |
| Operating Profit | 1,050 | 906 | 139 | 820 | -1,961 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,040 | 900 | -29.1 | 736 | -2,132 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 810 | 704 | -10.1 | 549 | -2,052 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 810 | 704 | -10.1 | 549 | -2,052 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 811 | 704 | -10.1 | 549 | -2,052 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 18.9 | 16.6 | 1.14 | 11.7 | -10.9 |